A bioengineered scaffold containing hypoxia-preconditioned, allogeneic human MSCs combined with a beta-adrenergic antagonist, timolol, to treat diabetic wounds in mice. The optimized treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback